Ignite Creation Date:
2025-12-24 @ 8:01 PM
Ignite Modification Date:
2025-12-28 @ 11:40 PM
Study NCT ID:
NCT00062504
Status:
TERMINATED
Last Update Posted:
2011-05-23
First Post:
2003-06-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization: